A clinical trial titled "Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome" was listed as recruiting on October 23, 2026. The trial, registered under identifier NCT07040748, does not have a specified phase, listed as not applicable. The study status is currently recruiting, according to the registry entry. This update relates to research involving leptin, a hormone with approved regulatory status. No results or outcomes have been posted for this trial at this time. The trial registry entry does not include information on findings, efficacy, or safety data. Readers interested in the broader context of this compound can consult the leptin overview for additional background information.
Trial Update: Leptin-Linked Study on VR Training in Metabolic Syndrome
Source: https://clinicaltrials.gov/study/NCT07040748